nms

Seminari di Oncologia

We are glad to host external speakers to present their latest findings at our Oncology Seminars Series. Usual topics include themes related to the biology of cancer, chemical approaches, and in general the application of current research and technologies to discover and develop innovative anti-cancer drugs. Please, see below upcoming and past events.

For attendance please contact 0331-581467/1478.

2017

  • October 24, 2017 (1:30 PM)
    TBA
    Giovanni Roti
    Dipartimento di Medicina e Chirurgia, Università di Parma
    Parma, Italy
  • October 23, 2017 (1:30 PM)
    Patient-Derived Xenograft technology in support to translational and clinical oncological research
    Stefano Cairo
    Research and Development Xentech
    Évry, France
  • October 20, 2017 (1:30 PM)
    TBA
    Beatrice Bodega, PhD
    Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi”, Policlinico
    Milano, Italy
  • September 28, 2017 (4:00 PM)
    Chordoma: rare cancer, uncommon opportunities
    Josh Sommer
    Chordoma Foundation, San Raffaele
    North Carolina
  • September 15, 2017 (11:30 AM)
    CAR-T cell therapy: challenges and opportunities
    Attilio Bondanza, MD PhD
    Innovative Immunotherapy Unit & Hematology and Bone Marrow Transplantation Unit, San Raffaele
    Milano, Italy
  • June 23, 2017 (1:30 PM)
    Integration of distinct endocytic pathways regulates the EGFR signaling output
    Sara Sigismund, PhD
    IFOM, The FIRC Institute for Molecular Oncology Foundation
    Milano, Italy
  • Jun 9, 2017 (1:30 PM)
    One, no one, and one hundred thousand: new clues to the riddle of the mutant p53 oncogene
    Gianni Del Sal
    Full Professor in Applied Biology, University of Trieste
    Head of the Molecular Oncology Unit at the Laboratorio Nazionale CIB
    Area Science Park,
    Trieste
  • May 19, 2017 (10:30 AM)
    Antibody-based immunotherapy of solid tumors
    Soldano Ferrone
    Harvard Medical School and Massachusetts General Hospital,
    Boston, USA
  • May 12, 2017 (1:30 PM)
    Patient derived tumor xenografts as a tool to improve ovarian patient prognosis
    Giovanna Damia
    Head, DNA Repair Unit,
    IRCCS - Istituto di Ricerche Farmacologiche Mario Negri
  • January 20, 2017 (1:30 PM)
    Glioblastoma standard of care and future directions
    Gaetano Finocchiaro
    Dipartimento di Neuro-Oncologia Molecolare,
    Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano

Archive 2016

  • December 13, 2016 (1:30 PM)
    Liver Cancer and the Stem-like Subset: the Challenge of Innovative Models
    Chiara Raggi
    Center for Autoimmune Liver Diseases
    IRCCS Istituto Clinico Humanitas, Rozzano
  • November 18, 2016 (1:30 PM)
    High-content single cell analysis of the human immune system by polychromatic flow cytometry: moving beyond 20 parameters
    Enrico Lugli
    Laboratory of Translational Immunology Humanitas Flow Cytometry Core
    Humanitas Clinical and Research Center Rozzano
  • October 25, 2016 (1:30 PM)
    Stato dell'arte e prospettive di cura in AML
    Alessandro Rambaldi
    Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
    University of Milan
  • July 25, 2016 (2:00 PM)
    Single-cell analysis of tumour infiltrating lymphocytes
    Massimiliano Pagani
    INGM and Medical Biotechnology and Translational Medicine Department
    University of Milan
  • July 19, 2016 (1:30 PM)
    From Neuroblastoma to Glioblastoma: the history of a hit-to-lead optimization
    Maurizio Botta
    Medicinal Chemistry
    Biotechnology Chemistry and Pharmacy Department, University of Siena
  • June 21, 2016 (1:30 PM)
    NGS as a tool for genome and transcriptome analysis
    Raffaele Calogero
    Bioinformatics and Genomics Unit
    Dipartimento di Biotecnologie e Scienze della Salute, Torino
  • June 20, 2016 (2:00 PM)
    Acute myeloid leukemia: news from the WHO; progress with IDH, FLT3 inhibitors
    Roberto Cairoli
    Dipartimento di Ematologia ed Oncologia
    Niguarda Cancer Center, Milano
  • June 14, 2016 (1:30 PM)
    Targeting pediatric acute lymphoblastic leukemia
    Giovanni Cazzaniga
    Diagnostic Laboratory and Molecular Genetics of Leukemia
    Centro Ricerca Tettamanti Pediatric Clinic, Univ. Milano Bicocca San Gerardo Hospital/Fondazione MBBM, Monza
  • April 1, 2016 (1:30 PM)
    LXR/LXR ligands and immune mediated control of tumor growth
    Vincenzo Russo
    Immuno-Biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology,
    San Raffaele Scientific Institute, Milan
  • March 22, 2016 (1:30 PM)
    iNKT cell control cancer progression by restraining pro-angiogenic tumor infiltrating macrophages
    Filippo Cortesi
    Experimental Immunology Unit
    Division of Immunology, Transplantation and Infectious Diseases DIBIT, H. San Raffaele Scientific Institute, Milano
  • February 19, 2016 (1:30 PM)
    The molecular control of hemoglobin switching
    Antonella E. Ronchi
    Dipartimento di Biotecnologie e Bioscienze
    Università degli studi di Milano Bicocca
  • February 12, 2016 (1:30 PM)
    Mechanisms of response and resistance to immune checkpoint blockade therapy in solid tumors
    Andrea Anichini
    Human Tumors Immunobiology Unit
    Dept. of Experimental Oncology and Molecular Medicine,Fondazione IRCCS Istituto Nazionale dei Tumori

Archive 2015

  • October 16, 2015 (1:30 PM)
    On the molecular mechanisms of chromatin modification
    Andrea Mattevi
    Laboratory of Biocrystallography Dept. of Biology and Biotechnology, University of Pavia
  • October 2, 2015 (1:30 PM)
    I modulatori dei recettori sigma quali potenziali farmaci antitumorali
    Simona Collina
    Dipartimento di Scienze del Farmaco, Sezione di Chimica e Tecnologia Farmaceutiche Università degli Studi di Pavia
  • July 23, 2015 (10:00 AM)
    Colorectal cancer precision medicine: from human tumors to preclinical models and back
    Enzo Medico
    Department of Oncology, University of Turin
  • July 7, 2015 (10:00 AM)
    Nuovi scenari nel trattamento del tumore del polmone e nuovo ruolo dell' immunoterapia
    Marina Chiara Garassino
    Oncologia Toraco-polmonare Dipartimento Medicina Oncologica Istituto Nazionale dei Tumori, Milan
  • June 16, 2015 (1:30 PM)
    Role of exosomes in immune suppression
    Licia Rivoltini
    Tumor Immunotherapy Unit,Istituto Nazionale Tumori, Milan
  • June 9, 2015 (1:30 PM)
    Discovery of NAMPT Inhibitors
    Giancesare Tron & Cristina Travelli
    Dipartimento di Scienze del Farmaco - Università degli Studi del Piemonte Orientale "A. Avogadro", Novara
  • May 7, 2015 (10:00 AM)
    Avanzamenti della terapia del carcinoma colon retto metastatico nel 2015: tradurre scoperte in terapie efficaci
    Salvatore Siena
    Dipartimento Ematologia ed Oncologia Ospedale Niguarda Ca’ Granda & Università di Milano
  • April 10, 2015 (1:30 PM)
    Recettori atipici per chemochine: ruolo biologico e meccanismi d'azione
    Massimo Locati
    Leukocyte Biology Lab, Humanitas Clinical and Research Center & General Pathology University, University of Milan
  • March 4, 2015 (4:30 PM)
    Clonal evolution and drug resistance: from cancer avatars to liquid biopsies
    Alberto Bardelli
    Institute for Cancer Research and Treatment (IRCC), University of Turin
  • February 20, 2015 (2:00 PM)
    Breast cancer and immune system: rationale for immunotherapy
    Giampaolo Bianchini
    Ospedale San Raffaele, Department of Medical Oncology, Milan

Archive 2014

  • July 25, 2014 (1:30 PM)
    Estrogen receptor alpha, a story of polymorphisms and endocrine responsiveness
    Paolo Ciana
    Center of Excellence on Neurodegenerative Diseases, Department of Pharmacological Sciences, University of Milan
  • July 11, 2014 (1:30 PM)
    Inhibition of the kinase STK4 triggers DNA damage-induced apoptosis in hematological cancers through the reactivation of hippo co-activator YAP1
    Giovanni Tonon
    Functional Genomics of Cancer Unit, Division of Molecular Oncology, San Raffaele Scientific Institute, Milan
  • June 17, 2014 (2:30 PM)
    Stem Cells: From their discovery to Phase I clinical trials for neurodegenerative and oncological diseases
    Angelo Vescovi
    University of Milan Bicocca; IRCCS Casa Sollievo della Sofferenza, S. Giovanni Rotondo; Institute for Tissue Engineering, Ospedale Niguarda, Milan
  • May 16, 2014 (1:30 PM)
    Theranostic proof-of-concept of immuno-retargeting of a prognostic tumour marker
    Roberto Perris
    Centre for Molecular and Translational Oncology - University of Parma & Division for Experimental Oncology 2 - CRO National Cancer Insitute, Aviano
  • March 21, 2014 (1:30 PM)
    Radiotracers and new drugs
    Erminia Fontana & Alberto Ghiglieri
    Isotope Chemistry, Accelera, Nerviano
  • February 7, 2014 (1:15 PM)
    La terapia medica dei tumori negli anziani
    Silvio Monfardini
    Divisione di Oncologia Geriatrica, Istituto L. Palazzolo - Fondazione Don Gnocchi, Milano
  • January 31, 2014 (1:30 PM)
    Epithelial cell identity disruption and breast cancer development - current notions and future perspectives
    Saro Oriana
    Centro di Senologia della Casa di Cura Ambrosiana, Cesano Boscone (MI), Institute of Medical Statistics and Biometry, University of Milan
    Danila Coradini
    Institute of Medical Statistics and Biometry, University of Milan

Archive 2013

  • December 12, 2013 (11:00 AM)
    Synthesis and biomedical applications of tumor targeting integrin ligands and conjugates
    Cesare Gennari
    Dipartimento di Chimica Organica ed Industriale, Università di Milano
  • October 25, 2013 (1:30 PM)
    Le aldeidi ossidasi: una famiglia di enzimi di crescente importanza per il metabolismo dei farmaci
    Enrico Garattini
    Molecular Pharmacology Laboratory, Istituto di Ricerche Farmacologiche "Mario Negri", Milan
  • May 3, 2013 (1:30 PM)
    Design and Synthesis of Potential Anticancer Compounds. Topoisomerases, Tubulin and Tyrosine Kinases as Biological Targets
    Daniele Passarella
    University of Milan
  • January 11, 2013 (1:30 PM)
    Screening capabilities within the IIT network
    Mark Wade
    Center for Genomic Science, Italian Institute of Technology, Milan

Archive 2012

  • November 5, 2012 (10:00 AM)
    Facilitating multi-site studies involving human tissue
    Zdenka Prodanovic
    Southern Health, Victorian Cancer Biobank, Clayton, Australia
  • October 19, 2012 (1:30 PM)
    Population PK/PD modeling to optimize drug development
    Francesco Fiorentini
    Pharmacokinetics, DMPK & ART, Accelera, Nerviano
  • October 11, 2012 (11:30 AM)
    Proseek multiplex for high throughput proteomics
    Patrik Lindstedt
    Olink Bioscience, Uppsala, Sweden
  • September 28, 2012 (1:30 PM)
    Model based drug development in Oncology from in vitro studies to the clinic
    Massimiliano Germani
    Pharmacokinetics Unit, Accelera, Nerviano
  • September 14, 2012 (1:30 PM)
    Is Drug Discovery still possible in Academia? The antimalarian Experience at the University of Milan
    Sergio Romeo
    Dipartimento Scienze Farmaceutiche "Pietro Pratesi", Facoltà di Farmacia, Università degli Studi di Milano
  • June 22, 2012 (1:30 PM)
    From nose to fertility: the long migratory journey of neuroendocrine GnRH-cells
    Anna Cariboni
    Dept. of Pharmacological and Biomolecular Sciences, University of Milan, and Dept. of Cell and Developmental Biology, University College London, UK
  • June 8, 2012 (1:30 PM)
    Constrain amino acids as building blocks for the preparation of peptidomimetics
    Maria Luisa Gelmi
    Istituto di Chimica Organica “Alessandro Marchesini” Università degli Studi di Milano, Milano
  • April 20, 2012 (1:30 PM)
    Inscuteable and NuMA bind competitively to LGN: Structure and implications for asymmetric cell divisions
    Marina Mapelli
    European Institute of Oncology, Milano
  • April 13, 2012 (1:30 PM)
    ArrayCGH provides insights into the pathogenesis of diffuse large B-cell lymphomas
    Francesco Bertoni
    Institute of Oncology Research, Bellinzona, Switzerland
  • March 23, 2012 (2:30 PM)
    RNAi Genetic screening for drug target discovery
    Paul Diehl
    Cellecta, Mountain View, CA, USA
  • March 13, 2012 (1:30 PM)
    Abnormal Choline Phospholipid metabolism in ovarian cancer
    Egidio Iorio
    Istituto Superiore di Sanità, Roma
  • March 9, 2012 (1:30 PM)
    Clinical bioinformatics: a research agenda to support health care transformation
    Riccardo Bellazzi
    University of Pavia and Biomedical Informatics Laboratory, IRCCS Fondazione S. Maugeri, Pavia
  • January 27, 2012 (1:30 PM)
    The search for novel multicomponent reactions: new strategies and molecular scaffolds useful for the medicinal chemist
    Gian Cesare Tron
    Università del Piemonte Orientale, Novara
  • January 20, 2012 (1:30 PM)
    Targeting development of urothelial cancer
    Andrea Necchi
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Archive 2011

  • December, 16 2011 (1:30 PM)
    Transcriptional control in inflammation and cancer
    Gioacchino Natoli
    IFOM-IEO Campus, Milano
  • December, 5 2011 (1:30 PM)
    The state of the art of regenerative medicine and surgery. The future is here ?
    Mario Marazzi
    A.O. Ospedale Niguarda Ca' Granda, Milano
  • December, 2 2011 (1:30 PM)
    Profili genetici ed epigenetici del carcinoma colorettale
    Daniela Furlan
    University of Insubria, Varese
  • November, 28 2011 (1:30 PM)
    Molecular analysis of mitotic kinase inhibitors
    Patrick Eyers
    YCR Institute for Cancer Studies, School of Medicine, University of Sheffield, U.K.
  • November, 18 2011 (1:30 PM)
    I batteri come agenti antitumorali
    Maria Rescigno
    Department of Experimental Oncology. European Institute of Oncology, Milano
  • November, 9 2011 (1:30 PM)
    Adventurous TR(i)PS: Deorphanizing ion channels with natural product ligands
    Giovanni Appendino
    Università degli Studi del Piemonte Orientale "Amedeo Avogadro, Novara
  • October, 19 2011 (1:30 PM)
    Chromatin Binding, Nucleosome Spacing and NcRNA Mediated Regulation of the Remodeling ATPase ISWI
    Davide Corona
    Università di Palermo
  • September, 16 2011 (1:30 PM)
    Analisi quantitativa delle immagini
    Maurizio Abbate
    Immagini e Computer, Bareggio
  • July, 26 2011 (10:00 AM)
    ANKRD26: un nuovo gene responsabile di piastrinopenia ereditaria e predisposizione alla leucemia
    Carlo Balduini
    Università di Pavia - Fondazione IRCCS Policlinico San Matteo, Pavia
  • July, 22 2011 (1:30 PM)
    New sugar-derived bioactive compounds: synthesis and biological characterization
    Francesco Peri
    University of Milan-Bicocca, Milan
  • July, 8 2011 (1:30 PM)
    The influence of increasing aromatic and aliphatic ring counts on compounds developability parameters
    Timothy Ritchie
    TJR-Chem, Ranco (Va)
  • June, 24 2011 (1:30 PM)
    Exploring chemical diversity in the field of natural products and of peptidomimetics
    Giordano Lesma
    Università degli Studi di Milano
  • June, 15 2011 (1:30 PM)
    Use of Native-MS in Drug Discovery
    Denis Zeyer
    NovAliX, Illrich
  • May, 27 2011 (1:30 PM)
    L'approccio olistico nelle leucemie infantili: la ricerca nella clinica
    Momcilo Jankovic
    Day Hospital of Haematology Department at San Gerardo Hospital in Monza
  • May, 20 2011 (1:30 PM)
    Genetic and functional analysis of Non-Hodgkin lymphoma determinants
    Stefano Casola
    IFOM- FIRC Institute of Molecular Oncology Foundation, Milan
  • May, 13 2011 (1:30 PM)
    The in-vivo functions of the tumor suppressor Prdm5 in development and disease
    Giorgio Galli
    BRIC / Copenhagen University, Denmark
  • April, 22 2011 (11:00 AM)
    Are FGF and FGFR promising targets?
    Filippo de Braud
    European Institute of Oncology, Milan
  • April, 19 2011 (2:00 PM)
    Tumori testa e collo: la prospettiva del clinico
    Lisa Licitra
    Fondazione IRCCS Istituto Nazionale Tumori, Milano
  • March, 11 2011 (1:30 PM)
    Organotypic Tissue Cultures: a useful platform for drug evaluation?
    Silvano Bosari
    University and Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano
  • March, 4 2011 (1:30 PM)
    Ligands targeting muscarinic or nicotinic cholinergic receptors: a personal viewpoint
    Marco DeAmici
    Dipartimento di Scienze Farmaceutiche, Università di Milano
  • March, 3 2011 (2:00 PM)
    La terapia medica dei sarcomi
    Paolo Casali
    Fondazione IRCCS Istituto Nazionale Tumori, Milano
  • February, 23 2011 (11:00 AM)
    Time-lapse video microscopy meets screening: novel cell-based phenotypic assays
    Del Trezise
    European Discovery Services Essen Bioscience in Hertfordshire, UK
  • February, 18 2011 (1:30 PM)
    Molecular classification of multiple myeloma
    Antonino Neri
    University of Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano
  • January, 28 2011 (1:30 PM)
    Network biology: a tool for oncology?
    Enrico Bucci
    BioDigitalValley, Pont Saint Martin
  • January, 18 2011 (1:30 PM)
    Targeted therapies for lung cancer
    Francesco Grossi
    National Institute for Cancer Research, Genova

Archive 2010

  • November, 12 2010 (1:30 PM)
    Predictive biomarkers of clinical outcome in colorectal cancer
    Andrea Sartore Bianchi
    Niguarda Ca' Granda Hospital, Milano
  • October, 5 2010 (1:30 PM)
    Advanced NSCLC: standard of care and perspectives
    Silvia Novello
    University of Turin, Orbassano
  • September, 24 2010 (1:30 PM)
    Genomic instability and the evolution of cancer
    Francesca Ciccarelli
    IFOM-IEO Campus, Milano
  • June, 25 2010 (1:30 PM)
    From oncogenome mining to functional validation of cancer genes
    Giovanni Tonon
    Oncology Department, San Raffaele Scientific Institute, Milano
  • June, 4 2010 (1:30 PM)
    Pain research in drug discovery: experimental models for target identification and validation
    Angelo Reggiani
    Istituto Italiano di Tecnologia, Genova

Archive 2009

  • November, 27 2009 (1:30 PM)
    Targeting human RNA helicases in viral and cancer diseases
    Giovanni Maga
    Institute of Molecular Genetics IGM-CNR, Pavia, Italy
  • November, 6 2009 (1:30-2:30 PM)
    Understanding kinase regulation and selective inhibition using large scale structural comparison
    Stefan Knapp
    Professor of Structural ChemistryStructural Genomics Consortium,University of Oxford
    Oxford, UK
  • October, 23 2009 (1:30-2:30 PM)
    Turning proteotoxic stress against cancer: the proteasome lessons
    Dr Simone Cenci
    Division of Genetics and Cell Biology,San Raffaele Scientific Institute
    via Olgettina,Milano
  • September, 25 2009 (1:30-2:30 PM)
    De Novo enzyme design for Green chemistry applications
    Artur Gora
    Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences
    Krakow, Poland
  • September, 11 2009 (1:30-2:30 PM)
    Overload in the protein factory. Turning ER stress against cancer
    Roberto Sitia
    Professor of Molecular Biology Università,Director Division of Genetics and Cell Biology, San Raffaele Scientific Institute
    Via Olgettina 58, 20132 Milano
  • July, 24 2009 (1:30-2:30 PM)
    Feedback control of mitosis
    Andrea Musacchio
    Dept. of Experimental Oncology,European Institute of Oncology
    Via Adamello 16, Milano
  • July, 10 2009 (1:30-2:30 PM)
    Analysis of gene expression in stage I epithelial ovarian cancer by Sergio Marchini
    Sergio Marchini
    Dipartimento Oncologia, Laboratorio Chemioterapia Antitumorale
    Istituto Mario Negri, Milano
  • June, 19 2009 (1:30-2:30 PM)
    Antigen stimulation in B cell neoplasia: the model of chronic lymphocytic leukemia
    Paolo Ghia
    Università Vita-Salute San Raffaele
    Via Olgettina 58, Milano
  • June, 12 2009 (1:30-2:30 PM)
    Extended replicative-potential and increased frequency of symmetric self-renewing divisions in cancer stem cells due to attenuated p53-signaling
    Giuseppina Bonizzi
    Department of Experimental Oncology
    European Institute of Oncology, Milano
  • May, 22 2009 (1:30-2:30 PM)
    NAD metabolism in health and disease: a structural biology perspective
    Menico Rizzi
    DISCAFF (Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche) Università del Piemonte Orientale "Amedeo Avogadro"
    Via Giovanni Bovio 6, 28100 Novara, Italy
  • May, 6 2009 (2:00-3:00 PM)
    The role of Hsp90 and the Rvb1-Rvb2-Tah-Pih1 complex in ribosomal RNA processing
    Walid Houry
    1 King's College Circle Medical Sciences Building,Department of Biochemistry,University of Toronto
    Toronto, Ontario
  • February, 20 2009 (1:30-2:30 PM)
    Therapeutic Advances in Colorectal Cancer: Identification of Predictive Biomarkers of Clinical Benefit
    Salvatore Siena
    Director of The Falck Division of Medical Oncology Ospedale Niguarda Ca' Granda
    Piazza Ospedale Maggiore 3, Milano
  • February, 13 2009 (1:30-2:30 PM)
    Leucemia acuta mieloide con mutazione della nucleophosmina: aspetti biologici e clinici
    Brunangelo Falini
    Institute of Hematology
    University of Perugia, Perugia
  • January, 30 2009 (1:30-2:30 PM)
    NAD(P): much more than basic metabolism. From signal transduction to cancer therapy
    Armando Genazzani
    Dip. di Scienze chimiche, Alimentari, Farmaceutiche e Farmacologiche
    Università degli Studi del Piemonte Orientale, Novara
  • January, 16 2009 (1:30-2:30 PM)
    Nuove terapie per le malattie mieloproliferative croniche
    Alessandro Rambaldi
    Direttore del reparto di Ematologia-Ospedali riuniti di Bergamo
    Bergamo

Archive 2008

  • December, 12 2008 (13:30-14:30 PM)
    Genomics of uveal melanoma: prognosis and target identification
    Ulrich Pfeffer
    National Cancer Research Institute
    Genova, Italy
  • November, 21 2008 (1:30-2:30 PM)
    Lanthanide complexes for sensing and imaging: magnetic resonance and emission probes
    David Parker
    Department of Chemistry
    Durham University, UK
  • November, 14 2008 (1:30-2:30PM)
    The impact of pharmacogenomics and pharmacokinetic on drug efficacy and drug toxicity
    Prof Mauro Magnani
    Istituto di Chimica Biologica "G. Fornaini",Università degli Studi "Carlo Bo"
    Urbino
  • November, 7 2008
    The CD38/NAD+/Cyclic ADP-ribose/intracellular calcium signalling pathway: mechanisms and therapeutic outlook
    Antonio De Flora
    Department of Experimental Medicine Center of Excellence for Biomedical Research of Genova
    Genova
  • October, 24 2008 (1:30-2:30 PM)
    From Mad Cow Disease to Sepsis: how NMR can help
    Luigi Calzolai
    Medway School of Pharmacy, Universities of Kent and Greenwich at Medway
    Chatham Maritime,Kent
  • October, 17 2008 (10:00-11:00 )
    T-cell gene manipulation by chimeric TcR for innovative treatment of acute leukemia
    Andrea Biondi
    Dipartimento di Medicina Clinica e Prevenzione Direttore, Centro Ricerca M. Tettamanti
    Monza (Italy)
  • October, 10 2008 (1:30-2:30 PM)
    Molecular imaging modalities in translational cancer research
    Boudewijn Lelieveldt
    Division of Image Processing,Department of Radiology,Leiden University Medical Center
    Leiden, The Netherlands
  • September, 26 2008 (1:30-2:30PM)
    Cancer mutations and targeted therapies
    Alberto Bardelli
    Laboratory of Molecular Genetics-The Oncogenomics Center, Institute for Cancer Research and Treatment (IRCC)
    Candiolo (Torino)
  • September, 12 2008 (1:30-2:30 PM)
    Leucemia acuta mieloide con mutazione della nucleophosmina:aspetti biologici e clinici
    Brunangelo Falini
    Institute of Hematology University of Perugia
    Perugia
  • September, 5 2008 (1:30-2:30PM)
    The petidyl prolyl isomerase Pin1 is a novel pharmacological target in cancer therapy: enhanced responses of acute myeloid leukemia cells to retinoids
    Enrico Garattini
    Laboratory of Molecular Biology,Istituto di Ricerche Farmacologiche "Mario Negri"
    Via La Masa, 19 Milano
  • July, 18 2008 (1:30-2:30 PM)
    Mode and dynamics of protein-DNA interactions at a human replication origin
    Arturo Falaschi
    Professore di Biologia Molecolare Scuola Normale Superiore
    Pisa
  • July, 4 2008 (1:30- 2:30 PM)
    Mutations of NPM in Acute Myeloid Leukemia
    Emanuela Colombo
    IFOM-IEO
    Milano
  • June, 27 2008 (11:30-12:30 PM)
    Therapeutic potential of cancer stem cells from solid tumors
    Ruggero De Maria
    Isituo Superiore Sanità
    Roma
  • June, 20 2008 (1:30-2:30 PM)
    Polyamines: old molecules, new syntheses, new opportunities. The multicomponent reactions protagonist in the medicinal chemistry
    Gian Cesare Tron
    Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center
    Università Studi del Piemonte Orientale A. Avogadro-Novara
  • May, 30 2008 (1:30-2:30 PM)
    CDC25 phosphatases. Cell cycle regulators and therapeutic targets
    Bernard Ducommun
    Institut d'Exploration Fonctionnelle des Génomes
    Toulouse
  • May, 23 2008 (1:30- 2:30 PM)
    Targeting breast cancer: from the benchside to the bed and vice versa
    Giancarlo Pruneri
    Division of Pathology and Laboratory Medicine European Institute of Oncology
    Milano
  • May, 16 2008 (1:30-2:30 PM )
    The role of the human mismatch repair system in drug resistance
    Josef Jiricny
    Institute of Molecular Cancer Research,University of Zürich
    Zürich
  • May, 9 2008 (1:30-2:30 PM)
    Vascuar tumor targeting: from the bench to the clinic
    Dario Neri
    Institute of Pharmaceutical Sciences
    Swiss Federal Institute of Technology, Zurich
  • April, 2 2008 (2:30-3:30 PM)
    The ubiquitin-dependent chaperone VCP/p97/Cdc48 regulates Aurora-B activity on mitotic chromatin
    Hemmo Meyer
    ETH Swiss Federal Institute of Technology
    Zurich
  • February, 1 2008 (1:30- 2:30 PM)
    Cancer mortality trends in the European Union: priorities for cancer control
    Carlo La Vecchia
    Head, Laboratory of General Epidemiology,Istituto di Ricerche Farmacologiche "Mario Negri"
    Milano

Archive 2007

  • December, 18 2007 (2-3 PM)
    Activation and down-regulation of tyrosine receptors: two models for anti-cancer therapy
    Giovanni Gaudino
    University of Piemonte orientale “A.Avogadro”
    Novara
  • December, 4 2007 (2 PM)
    Oncology Exploration - panning for gold in biomolecular space
    David Lloyd
    School of Biochemistry and Immunology Trinity College
    Trinity College Dublin, Dublin 2, Ireland
    Email: lloyddg@tcd.ie
  • November, 23 2007 (2,30-3,30 PM)
    The mitochondrial regulation of cell death and its possible therapeutic implications
    Sten Orrenius
    Institute of Environmental Medicine,Division of Toxicology- Karolinska Institutet
    Stockholm, Sweden
  • November, 6 2007 (2-3 PM)
    Molecular targeted therapie of cronic myelogeneus leukemia
    Tim Bruemmendorf
    Klinik für Onkologie/Hämatologie
    Hamburg
  • October, 16 2007 (2-3 PM)
    "New approaches for virtual screening"
    Giulio Rastelli
    Dipartimento di Scienze Farmaceutiche Facolta' di Bioscienze e Biotecnologie Universita' di Modena e Reggio Emilia
  • October, 9 2007 (2-3 PM)
    Computational tools to predict chemical properties, with emphasis on toxicity and endocrine disruption".
    Emilio Benfenati
    Laboratory of Environmental Chemistry and Toxicology, istituto di Ricerche Farmacologiche "Mario Negri"
    via La Masa 19, Milano
    Email: benfenati@marionegri.it
  • October, 2 2007 (2-3 PM)
    Post-translational modifications in disease pathogenesis: examples from proteomic studies on a neurodegenerative disorder
    Valentina Bonetto
    Istituto di Ricerche Farmacologiche "Mario Negri", Milano,Italy
    Email: bonetto@marionegri.it
  • September, 25 2007 (2-3 PM)
    Inflammation and cancer: from biology to target validation
    Alberto Mantovani
    Istituto Clinico Humanitas
    Milan, italy
  • September, 11 2007 (2-3 PM)
    Prognostic and therapeutic implications of cancer stem cells from solid tumors
    Ruggero De Maria
    Istituto Superiore di Sanità-Roma
  • September, 4 2007 (2,30-3,30 PM)
    Integrins, mediators and therapeutic targets of tumor angiogenesis and metastasis
    Curzio Ruegg
    CePO and ISREC
    Epalinges, Switserland
  • July, 17 2007 (2-3 PM)
    A quantitative analysis of the cell cycle molecular regulatory network
    Andrea Ciliberto
    Computational Cell Biology, IFOM
    Via Adamello 16 I-20141 Milan, Italy
  • June, 19 2007 (2-3 PM)
    Therapeutic monoclonal antibodies in oncohematology:factors affecting efficacy
    Josee Golay
    Division of Hematology, Ospedali Riuniti, Bergamo,Italy
  • June, 19 2007 (2-3 PM)
    Josee Golay and Martino Introna
    Laboratory of Cellular and Gene Therapy "G. Lanzani"
  • May, 22 2007 (11-12 AM)
    Translational Research Unit, Unit 10 Department of Experimental Oncology and Laboratories
    Maria Grazia Daidone
    Istituto Nazionale per lo Studio e la Cura dei Tumori
    Via Venezian, 1, 20133 Milan, Italy
  • May, 15 2007 (2- 3 PM)
    Multicomponent reactions and click chemistry: new potent tools for the synthetic medicinal chemist
    Gian Cesare Tron
    Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center Universita degli Studi del Piemonte Orientale A. Avogadro
    Via Bovio 6, 28100 Novara, Italy
    Email: tron@pharm.unipmn.it
  • April, 10 2007 (2:00 PM)
    Reazioni stereoselettive promosse da catalizzatori organici e organometallici
    Maurizio Benaglia
    University of Milano
  • April, 3 2007 (2 - 3 PM)
    Deoxynucleoside kinases as tools in drug discovery and therapy monitoring
    Staffan Eriksson
    Department of Anatomy, Physiology and Biochemistry The Swedish University of Agricultural Sciences, BMC
  • March, 27 2007 (2 - 3 PM)
    Sensing and responding to DNA damage
    Noel Lowndes
    Genome Stability Laboratory Department of Biochemistry and National Centre for Biomedical Engineering Science National University of Ireland Galway, Ireland
  • March, 13 2007 (2 - 3 PM)
    Impact of biocatalysis on the quality of pharmaceutical ingredients
    Marco Terreni
    Pharmaceutical Biocatalysis Laboratories Università degli Studi di Pavia and INNOVATE BIOTECHNOLOGY S.r.l.
  • March, 6 2007 (2:00 PM)
    Pro-apoptotic activity of NBDHEX, a suicide inhibitor of glutathione transferases
    Anna Maria Caccuri
    University of Rome "Tor Vergata", Rome
  • February, 27 2007 (2:00 PM)
    Angiogenesis and the tumor microenvironment as target fot therapy and cancer prevention
    Adriana Albini
    IRCCS Multimedica, Milano
  • February, 13 2007 (2:00 PM)
    Environmentally Friendly Synthesis of Biological Polyfunctionalized Molecules Based on a CeCl3•7H2O-Nal Promoter
    Enrico Marcantoni
    University of Camerino, Camerino, Italy
  • February, 6 2007 (2:00 PM)
    DNA Repair at a Atomic Resolution
    Thomas Carell
    Ludwig-Maximilians University, München, Germany
  • January, 30 2007 (2:00 PM)
    New Theme in Cell Migration
    Federico Bussolino
    IRCC, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy
 
Per offrirti un'esperienza di navigazione ottimizzata NMS Group e le società controllate utilizzano cookies, anche di terze parti.
Proseguendo con la navigazione acconsenti al loro impiego in conformità della nostra  
Cookie Policy.